Adial Pharmaceuticals, Inc (ADIL) insider trading
Every open-market stock purchase and sale by Adial Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $206K over the last 12 months (4 buys).
- Last insider buy: Coastlands Capital LP (10% owner), $3.4K, 3 months ago.
Last 12 months: insiders bought $206K (4 buys) and sold $0 (0 sales). Last close $4.11 on Oct 21, 2026.
Recent ADIL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 17, 2026 | Wendy B. Young (Director) | Bought (not open market) | — |
| Jul 16, 2026 | Coastlands Capital LP (10% owner) | Bought | $3.4K |
| Jul 14, 2026 | Coastlands Capital LP (10% owner) | Bought | $5.3K |
| Jul 10, 2026 | Coastlands Capital LP (10% owner) | Bought | $4.6K |
| Jul 9, 2026 | Coastlands Capital LP (10% owner) | Bought | $28K |
| Jun 29, 2026 | Coastlands Capital LP (10% owner) | Bought | $65K |
| Jun 12, 2026 | Wendy B. Young (Director) | Bought | $100K |
| Jun 12, 2026 | Matt Davidson (C-suite exec) | Bought (not open market) | — |
| Jun 11, 2026 | Matt Davidson (C-suite exec) | Bought (not open market) | — |
| Jun 11, 2026 | Matt Davidson (C-suite exec) | Bought (not open market) | — |
| Jun 11, 2026 | Matt Davidson (C-suite exec) | Bought (not open market) | — |
| Jun 11, 2026 | Matt Davidson (C-suite exec) | Bought (not open market) | — |
| Apr 7, 2026 | Cary J Claiborne (CEO) | Bought (not open market) | — |
| Apr 7, 2026 | Robertson H. Gilliland (Director) | Bought (not open market) | — |
| Apr 7, 2026 | Kevin Schuyler (Director) | Bought (not open market) | — |
| Apr 7, 2026 | Vinay Shah (CFO) | Bought (not open market) | — |
| Apr 7, 2026 | Tony Goodman (COO) | Bought (not open market) | — |
| Apr 7, 2026 | J. Kermit Anderson (Director) | Bought (not open market) | — |
Who's trading ADIL
- Wendy B. Young, Director: bought $100K (1 buy), last Sep 17, 2026
- Coastlands Capital LP, 10% owner: bought $106K (5 buys), last Jul 16, 2026
- Matt Davidson, C-suite exec: other filings, last Jun 12, 2026
- J. Kermit Anderson, Director: other filings, last Apr 7, 2026
- Kevin Schuyler, Director: other filings, last Apr 7, 2026
- Vinay Shah, CFO: other filings, last Apr 7, 2026
- Tony Goodman, COO: other filings, last Apr 7, 2026
- Cary J Claiborne, CEO: other filings, last Apr 7, 2026
- Robertson H. Gilliland, Director: other filings, last Apr 7, 2026
Get free alerts when an insider at Adial Pharmaceuticals, Inc files a new trade →